Home › Free Stock Grades › OBIO
Orchestra BioMed Holdings, Inc. (OBIO) Stock Grade
OBIO · Healthcare
C
Market Cap
$352.7M
P/E Ratio
—
Revenue Growth (YoY)
+1169.2%
Net Margin
-157.4%
Return on Equity
—
Dividend Yield
None
About Orchestra BioMed Holdings, Inc.'s fundamentals
Orchestra BioMed is a small-cap biotechnology company with a market capitalization of $352.7 million that generated extraordinary revenue growth of 1,169.2% year-over-year, indicating rapidly expanding commercial activity. However, the company operates at a significant loss with a net margin of -157.4%, meaning it spent $2.57 for every dollar of revenue generated in its latest reporting period. The company does not pay a dividend and reported a net loss in its most recent annual statement, reflecting the capital-intensive nature of its business as it scales operations.